Slate Path Capital LP Teva Pharmaceutical Industries LTD Transaction History
Slate Path Capital LP
- $4.98 Billion
- Q1 2024
A detailed history of Slate Path Capital LP transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Slate Path Capital LP holds 26,896,184 shares of TEVA stock, worth $455 Million. This represents 7.63% of its overall portfolio holdings.
Number of Shares
26,896,184
Previous 26,231,184
2.54%
Holding current value
$455 Million
Previous $274 Million
38.58%
% of portfolio
7.63%
Previous 6.1%
Shares
4 transactions
Others Institutions Holding TEVA
# of Institutions
539Shares Held
548MCall Options Held
19.8MPut Options Held
14M-
Black Rock Inc. New York, NY43.7MShares$740 Million0.01% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E938.6MShares$653 Million36.28% of portfolio
-
Phoenix Holdings Ltd. Givatayim, L334.6MShares$585 Million7.05% of portfolio
-
Migdal Insurance & Financial Holdings Ltd.29.9MShares$505 Million6.74% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L328.8MShares$487 Million4.57% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $18.8B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...